Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking (Q40330842)

19 September 2017

Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking (English)

1 reference

19 September 2017

Shoufa Han

1

1 reference

19 September 2017

Brian E Collins

series ordinal

2

1 reference

19 September 2017

Per Bengtson

series ordinal

3

1 reference

19 September 2017

James C Paulson

series ordinal

4

1 reference

19 September 2017

12 June 2005

1 reference

19 September 2017

Nature Chemical Biology

1 reference

19 September 2017

1

1 reference

19 September 2017

2

1 reference

19 September 2017

93-97

1 reference

https://scigraph.springernature.com/pub.10.1038/nchembio713

19 September 2017

0 references

cites work

Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Expanding the diversity of unnatural cell-surface sialic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Cell surface engineering by a modified Staudinger reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Immune regulation by the ST6Gal sialyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

7 January 2021

Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

7 January 2021

Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

7 January 2021

Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

7 January 2021

A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO713

7 January 2021

Identifiers

DOI

10.1038/NCHEMBIO713

1 reference

19 September 2017

1 reference